Tech Transfer eNews Blog
University-Industry Engagement Advisor

Air Force lab licenses out technology that could help vets with PTSD

By Jesse Schwartz
Published: September 5th, 2018

The U.S. Air Force Research Laboratory (AFRL) has licensed out a technology that could help military veterans suffering from post-traumatic stress disorder (PTSD).

Boston-based start-up Elke Therapeutics aims to commercialize the innovation, which targets a peptide that is found naturally in the brain, known as neuropeptide Y. High levels of the peptide are associated with PTSD and drug addiction. By manipulating the compound, Elke Therapeutics hopes to control its fluctuations in patients.

“This has an immense potential to improve healthcare,” says Stephanie Davis, the start-up’s chief scientist and founder.

Davis discovered the technology in an online database of available military research. TechLink, the tech transfer arm of the Department of Defense, launched the database to provide a streamlined platform for companies to license innovations from military labs.

Under the agreement with AFRL, Elke Therapeutics will pay an upfront licensing fee and four percent royalty on sales.

According to Davis, the start-up will move forward with the license to conduct in vitro and small animal studies. “As a part-time professor, I’ve had students who were combat vets with PTSD, and [I’ve] witnessed its effects,” she says. “Our long-term vision is to advance breakthrough products, and we’re structured for early-stage monetization to get us there.”

Source: EurekAlert!

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment